Search

Your search keyword '"Zinn-Justin, Sophie"' showing total 416 results

Search Constraints

Start Over You searched for: Author "Zinn-Justin, Sophie" Remove constraint Author: "Zinn-Justin, Sophie"
416 results on '"Zinn-Justin, Sophie"'

Search Results

6. KIF2C-induced nuclear condensation concentrates PLK1 and phosphorylated BRCA2 at the kinetochore microtubules in mitosis

8. The BRCA2 R2645G variant increases DNA binding and induces hyper-recombination

9. Mechanism of MRX inhibition by Rif2 at telomeres

10. BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination

12. BRCA2-HSF2BP oligomeric ring disassembly by BRME1 promotes homologous recombination

13. Chromosome Pairing Through Tensioned DNA Tethers Revealed by BRCA2 Meiotic Domain Deletion

16. BRCA2-HSF2BP oligomeric ring assembly is implicated in the regulation of homologous recombination during meiosis

20. Supplementary Figure 4. (A-D) from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

21. Data from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

22. Supplementary Figure 6. (A) from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

23. Supp tables from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

24. Supplementary Figure 1 (B). from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

25. Supplementary Figure 6. (B-C) from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

26. Supplementary Figure 2. Classification of the VUS as a function of the impact of the corresponding missense variations on BRCT domain expression in E. coli. from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

27. Supplementary Figure 3. Classification of the 42 purified mutated BRCT domains as a function of their thermostability as measured using a high throughput fluorescence assay. from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

28. Supplementary Figure 5. (A-B) from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

29. Supplementary Figure 1 (A). from Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

30. Polθ is phosphorylated by Polo-like kinase 1 (PLK1) to enable repair of DNA double strand breaks in mitosis

31. A De Novo Sequence Variant in Barrier-to-Autointegration Factor Is Associated with Dominant Motor Neuronopathy

32. BRCA2-HSF2BP oligomeric ring disassembly by BRME1 promotes homologous recombination

33. BRCA2-HSF2BP oligomeric ring disassembly by BRME1 promotes homologous recombination

34. The BAF A12T mutation disrupts lamin A/C interaction, impairing robust repair of nuclear envelope ruptures in Nestor-Guillermo progeria syndrome cells

35. The luminal domain of Toxoplasma gondii sortilin adopts a ring-shaped structure exhibiting motifs specific to apicomplexan parasites

39. Structural analysis of Toxoplasma gondiisortilin

42. Emerin self‐assembly mechanism: role of the LEM domain

45. Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial

47. Inhibitory signalling to the Arp2/3 complex steers cell migration

48. Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage

50. BRCA2 binding through a cryptic repeated motif to HSF2BP oligomers does not impact meiotic recombination

Catalog

Books, media, physical & digital resources